ArticleCancer prevention research (Philadelphia, Pa.)2024

Oncogenic HRAS Induces Metformin Resistance in Head and Neck Cancer by Promoting Glycolytic Metabolism.

Xingyu Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.